Two interesting research stories to follow up on:
A team of researchers at the National Cancer Institute has shown a regression of advanced melanoma in a study of 17 patients by genetically engineering autologous patients’ lymphocytes to recognize and attack neoplastic cells.
Activa® Deep Brain Stimulation (DBS) Therapy from Medtronic combined with medication was shown to be significantly more effective than medication alone in treating motor symptoms of advanced Parkinson’s disease.